Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Short Title: A151804

Enrollment Status: Recruiting

NCT #: NCT04242095

Specialty Area: Oncology

Condition Studied: Multi-Site Cancer

Age Groups: Child; Adult; Older Adult

Phase: Not Applicable

Study Information

Summary / Purpose

To collect blood, tissue, and other samples, along with related health information, from people who have experienced side effects during immunotherapy treatment. The goal is to help researchers better understand why these side effects happen and how they may be predicted, prevented, and treated in the future. There are no study treatments involved; participation may include sample collection and medical record review.

Study Type: Observational

Accepts Healthy Volunteers: No

Who Can Participate

Eligibility Criteria:

Children, Adults, and Older Adults 0+ years of age
Diagnosed with cancer and received one or more immunotherapy drugs
Experienced at least one significant immune-related side effect

What's Involved

Participation in the study will include:

Providing blood, tissue and other samples along with health information to be securley stored in a research biobank for future research
No investigational treatment and no extra visits beyond sample collection and record review

Principal Investigator

Max Coppes, MD

Pediatric Hematology-Oncology

A Member of

(775) 982–3970

Renown Medical Group - Pediatrics - Center F

View Provider

Additional Information

Location: Renown Health, Office of Clinical Research
Address:

1500 E 2nd St. Reno, NV 89502

General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org

Complete Study Details: https://clinicaltrials.gov/study/NCT04242095

Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.

Health & Wellness eNews